NEVAKAR INJECTABLES (SIX DEVELOPMENT-STAGE, READY-TO-USE INJECTABLE PRODUCT CANDIDATES)

Deals Overview

Total Deals1

Valued Deals1

Total Value£ 28 M

Avg. Deal Size£ 28 M

Market Context

Sort

nevakar injectables (six development-stage, ready-to-use injectable product candidates)

HQ - United States

Pharmaceuticals

2 May 2022

Investment Date

100%

Stake

£ 28 M

Deal Value

By continuing, you agree to our Terms & Conditions and our Data Privacy Policy